The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
Pancreatic ductal adenocarcinoma (PDAC) is still difficult to treat due to insufficient methods for early diagnosis and prediction of therapy response. Furthermore, surveillance after curatively intended surgery lacks adequate methods for timely detection of recurrence. Therefore, several molecules...
Saved in:
Main Authors: | Niklas Sturm, Thomas Jens Ettrich, Lukas Perkhofer |
---|---|
格式: | Revisão |
语言: | 英语 |
出版: |
2022
|
在线阅读: | https://doi.org/10.3390/cancers14010217 https://www.mdpi.com/2072-6694/14/1/217/pdf?version=1641282367 |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
相似书籍
-
The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
由: Sturm, Niklas, et al.
出版: (2022) -
Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling
由: Ettrich, Thomas J., et al.
出版: (2022) -
Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions
由: Niklas Sturm, et al.
出版: (2022) -
Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
由: Hongbeom Kim, et al.
出版: (2020) -
Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
由: Kim, Hongbeom, et al.
出版: (2020)